<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Actual problems in dentistry</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Actual problems in dentistry</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Проблемы стоматологии</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2077-7566</issn>
   <issn publication-format="online">2412-9461</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">123248</article-id>
   <article-id pub-id-type="doi">10.18481/2077-7566-2026-22-2-103-109</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>ХИРУРГИЧЕСКАЯ СТОМАТОЛОГИЯ И ИМПЛАНТОЛОГИЯ. ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>SURGICAL DENTISTRY AND IMPLANTOLOGY. ORIGINAL RESEARCH PAPERS</subject>
    </subj-group>
    <subj-group>
     <subject>ХИРУРГИЧЕСКАЯ СТОМАТОЛОГИЯ И ИМПЛАНТОЛОГИЯ. ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">ORAL CAVITY STATUS IN PATIENTS WITH MEDICATION-RELATED OSTEONECROSIS OF THE JAW BEFORE AND AFTER TREATMENT</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>СОСТОЯНИЕ ПОЛОСТИ РТА У ПАЦИЕНТОВ С МЕДИКАМЕНТОЗНО-АССОЦИИРОВАННЫМ ОСТЕОНЕКРОЗОМ ЧЕЛЮСТИ ДО И ПОСЛЕ ЛЕЧЕНИЯ</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Виноградова</surname>
       <given-names>Наталья Геннадьевна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Vinogradova</surname>
       <given-names>Natal'ya Gennad'evna</given-names>
      </name>
     </name-alternatives>
     <email>yagoda-77@mail.ru</email>
     <bio xml:lang="ru">
      <p>кандидат медицинских наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>candidate of medical sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Харитонова</surname>
       <given-names>Марина Павловна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Kharitonova</surname>
       <given-names>Marina P.</given-names>
      </name>
     </name-alternatives>
     <email>nocar@sosp.ru</email>
     <bio xml:lang="ru">
      <p>доктор медицинских наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>doctor of medical sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Упорова</surname>
       <given-names>Наталья Андреевна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Uporova</surname>
       <given-names>Natal'ya Andreevna</given-names>
      </name>
     </name-alternatives>
     <bio xml:lang="ru">
      <p>кандидат медицинских наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>candidate of medical sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Уральский государственный медицинский университет</institution>
     <city>Екатеринбург</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Уральский государственный медицинский университет</institution>
     <city>Екатеринбург</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Уральский государственный медицинский университет</institution>
    </aff>
    <aff>
     <institution xml:lang="en">Ural State Medical University</institution>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2026-06-29T19:24:06+03:00">
    <day>29</day>
    <month>06</month>
    <year>2026</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-06-29T19:24:06+03:00">
    <day>29</day>
    <month>06</month>
    <year>2026</year>
   </pub-date>
   <volume>22</volume>
   <issue>2</issue>
   <fpage>103</fpage>
   <lpage>109</lpage>
   <history>
    <date date-type="received" iso-8601-date="2026-05-13T00:00:00+03:00">
     <day>13</day>
     <month>05</month>
     <year>2026</year>
    </date>
   </history>
   <self-uri xlink:href="https://dental-press.ru/en/nauka/article/123248/view">https://dental-press.ru/en/nauka/article/123248/view</self-uri>
   <abstract xml:lang="ru">
    <p>Актуальность. Одонтогенная инфекция выступает ключевым триггером в патогенезе медикаментозно-ассоциированного остеонекроза челюсти. Неудовлетворительная гигиена полости рта усугубляет ситуацию – декомпенсируются очаги хронической одонтогенной инфекции, прогрессируют заболевания пародонта, что ведет к потере зубов и возникновению новых источников остеонекроза. На фоне хронического воспалительного процесса в полости рта становится невозможной полноценная санация полости рта и восстановление зубного ряда, что является одной из причин социальной дезадаптации пациента.&#13;
Цель: оценить состояние полости рта у пациентов с медикаментозно-ассоциированным остеонекрозом челюсти до и после комплексного лечения.&#13;
Материалы и методы. Исследование «случай-контроль». Обследованы 79 пациентов с медикаментозно-ассоциированным остеонекрозом челюсти. Все пациенты были пролечены по предложенной методике, включающей интраоперационное определение границ секвестрэктомии с применением лазерной доплеровской флоуметрии, обработку остаточных грануляции красным диодным лазером и инъекции аутологичной плазмы в края послеоперационной раны. Стоматологический статус пациентов устанавливали с использованием индексов интенсивности кариеса, упрощенного индекса гигиены рта по Грину-Вермиллиону (1964), папиллярно-маргинально-альвеолярного индекса в модификации Parma (1960). Индексы просчитывали по стандартной методике. Расчеты для статистического анализа проводили с помощью пакета анализа MS Excel 10 и Statistica 10.&#13;
Результаты. У всех обследованных пациентов была выявлена патология твердых тканей. Распространенность кариеса составляла 100 %. Средний индекс интенсивности кариеса (КПУ) составлял 20,06 ±5,58, среди них 11,4 % с полной вторичной адентией. Средний уровень упрощенного индекса гигиены рта составлял 2,5 ±0,07, папиллярно-маргинально-альвеолярного индекса – 54,67 ±15,65. Динамику стоматологических показателей оценивали через 2 месяца после лечения медикаментозно-ассоциированного остеонекроза челюсти. Индекс интенсивности кариеса становился больше (22,08 ±5,17), показатель упрощенного индекса гигиены рта – 1,61 ±0,5 балла, папиллярно-маргинально-альвеолярного индекса — 39,64 ±16,24 %. У 50,6 % пациентов была восстановлена целостность зубного ряда с использованием съемных ортопедических конструкции.&#13;
Заключение. Таким образом, предложенный метод комплексного лечения пациентов с медикаментозно-ассоциированным остеонекрозом челюсти позволяет купировать болевой синдром, устранить дефект слизистой оболочки альвеолярного отростка, провести полноценную санацию полости рта и восстановить целостность зубного ряда ортопедическими конструкциями.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>Introduction. Odontogenic infection acts as a key trigger in the pathogenesis of medication- related osteonecrosis of the jaw. Poor oral hygiene exacerbates the situation – foci of chronic odontogenic infection become decompensated, periodontal diseases progress, leading to tooth loss and the emergence of new sources of osteonecrosis. Chronic oral inflammation makes proper oral hygiene and dental restoration impossible, which is one of the causes of social maladjustment for the patient.&#13;
Objective: to evaluate the oral cavity condition in patients with drug-associated osteonecrosis of the jaw before and after complex treatment.&#13;
Materials and Methods. A case-control study. 79 patients with medication-related osteonecrosis of the jaw were examined. All patients were treated according to the proposed protocol, which included intraoperative determination of sequestrectomy margins using laser Doppler flowmetry, treatment of residual granulations with a red diode laser, and injections of autologous plasma into the edges of the postoperative wound. The dental status of patients was assessed using the following indices: the caries intensity index, the Simplified Oral Hygiene Index, and the Papillary-Marginal-Alveolar Index (1960). The indices were calculated according to standard methods. Calculations for statistical analysis were performed using the MS Excel 10 Analysis ToolPak and Statistica 10.&#13;
Results. Pathology of the hard tissues of all tooth groups was identified in all patients. The prevalence of caries was 100 %. The caries intensity index in the study group was 20.06 ±5.58, with 11.4 % of patients having complete secondary edentulism. The mean Simplified Oral Hygiene Index by Greene-Vermillion was 2.5 ±0.07. The mean Papillary-Marginal-Alveolar Index was 54.67 ±15.65. The dynamics of dental indicators were assessed 2 months after treatment. The caries intensity index increased (22.08 ±5.17), the mean Oral Hygiene Index score was 1.61 ±0.5, and the Papillary-Marginal-Alveolar Index decreased by 15.03 % (39.64 ±16.24). In 50.6 % of patients, the integrity of the dentition was restored using removable orthopedic prostheses.&#13;
Conclusion. Thus, the proposed method for the intraoperative determination of sequestrectomy boundaries and the algorithm for postoperative management and early rehabilitation of patients with medication-related osteonecrosis of the jaw makes it possible to alleviate pain, eliminate the mucosal defect of the alveolar process, perform a complete oral debridement, and restore the integrity of the dentition with orthopedic prostheses.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>медикаментозно-ассоциированный остеонекроз</kwd>
    <kwd>остеомодифицирующие агенты</kwd>
    <kwd>гигиена полости рта</kwd>
    <kwd>метод интраоперационного определения границ секвестрэктомии</kwd>
    <kwd>алгоритм реабилитации пациентов</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>medication-related osteonecrosis of the jaw</kwd>
    <kwd>bone-modifying agents</kwd>
    <kwd>oral hygiene</kwd>
    <kwd>method of intraoperative determination of sequestrectomy boundaries</kwd>
    <kwd>algorithm for patient rehabilitation</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Kühl S., Walter C., Acham S., Pfeffer R., Lambrecht J.T. Bisphosphonate-related osteonecrosis of the jaws-a review. Oral oncology. 2012;48(10):938-947. https://doi.org/10.1016/j.oraloncology.2012.03.028</mixed-citation>
     <mixed-citation xml:lang="en">Kühl S., Walter C., Acham S., Pfeffer R., Lambrecht J.T. Bisphosphonate-related osteonecrosis of the jaws-a review. Oral oncology. 2012;48(10):938-947. https://doi.org/10.1016/j.oraloncology.2012.03.028</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Khan A.A., Morrison A., Hanley D.A., Felsenberg D., McCauley L.K., O'Ryan F. et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of Bone and Mineral Research. 2015;30(1):3-23. https://doi.org/10.1002/jbmr.2405</mixed-citation>
     <mixed-citation xml:lang="en">Khan A.A., Morrison A., Hanley D.A., Felsenberg D., McCauley L.K., O'Ryan F. et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of Bone and Mineral Research. 2015;30(1):3-23. https://doi.org/10.1002/jbmr.2405</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lombard T., Neirinckx V., Rogister B., Gilon Y., Wislet S. Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches. Stem Cells International. 2016;2016:8768162. https://doi.org/10.1155/2016/8768162</mixed-citation>
     <mixed-citation xml:lang="en">Lombard T., Neirinckx V., Rogister B., Gilon Y., Wislet S. Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches. Stem Cells International. 2016;2016:8768162. https://doi.org/10.1155/2016/8768162</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Anesi A., Generali L., Sandoni L., Pozzi S., Grande A. From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights. International journal of molecular sciences. 2019;20(19):4925. https://doi.org/10.3390/ijms20194925</mixed-citation>
     <mixed-citation xml:lang="en">Anesi A., Generali L., Sandoni L., Pozzi S., Grande A. From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights. International journal of molecular sciences. 2019;20(19):4925. https://doi.org/10.3390/ijms20194925</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">De Sousa Ferreira V.C., Lopes A.P., Alves N.M., Sousa F.R.N., Pereira K.M.A., Gondim D.V. et al. Bisphosphonate-related osteonecrosis induced change in alveolar bone architecture in rats with participation of Wnt signaling. Clinical oral investigations. 2021;25(2):673-682. https://doi.org/10.1007/s00784-020-03551-7</mixed-citation>
     <mixed-citation xml:lang="en">De Sousa Ferreira V.C., Lopes A.P., Alves N.M., Sousa F.R.N., Pereira K.M.A., Gondim D.V. et al. Bisphosphonate-related osteonecrosis induced change in alveolar bone architecture in rats with participation of Wnt signaling. Clinical oral investigations. 2021;25(2):673-682. https://doi.org/10.1007/s00784-020-03551-7</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Hayano H., Kuroshima S., Sasaki M., Tamaki S., Inoue M., Ishisaki A. et al. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice. Bone. 2020;135:115308. https://doi.org/10.1016/j.bone.2020</mixed-citation>
     <mixed-citation xml:lang="en">Hayano H., Kuroshima S., Sasaki M., Tamaki S., Inoue M., Ishisaki A. et al. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice. Bone. 2020;135:115308. https://doi.org/10.1016/j.bone.2020</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Kawahara M., Kuroshima S., Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. International journal of implant dentistry. 2021;7(1):47. https://doi.org/10.1186/s40729-021-00323-0</mixed-citation>
     <mixed-citation xml:lang="en">Kawahara M., Kuroshima S., Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. International journal of implant dentistry. 2021;7(1):47. https://doi.org/10.1186/s40729-021-00323-0</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Kato S., Takashima H., Furuno S., Kako M., Maeda M., Hishida S. et al. A retrospective study on the incidence and risk factor of ARONJ. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2021;33(5):489-493. https://doi.org/10.1016/j.ajoms.2021.02.011</mixed-citation>
     <mixed-citation xml:lang="en">Kato S., Takashima H., Furuno S., Kako M., Maeda M., Hishida S. et al. A retrospective study on the incidence and risk factor of ARONJ. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2021;33(5):489-493. https://doi.org/10.1016/j.ajoms.2021.02.011</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">AlRowis R., Aldawood A., AlOtaibi M., Alnasser E., AlSaif I., Aljaber A. et al. Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies. The Saudi dental journal. 2022;34(3):202-210. https://doi.org/10.1016/j.sdentj.2022.01.003</mixed-citation>
     <mixed-citation xml:lang="en">AlRowis R., Aldawood A., AlOtaibi M., Alnasser E., AlSaif I., Aljaber A. et al. Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies. The Saudi dental journal. 2022;34(3):202-210. https://doi.org/10.1016/j.sdentj.2022.01.003</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gkouveris I., Hadaya D., Soundia A., Bezouglaia O., Chau Y., Dry S.M. et al. Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ). Bone. 2019;123:234-245. https://doi.org/10.1016/j.bone.2019.03.031</mixed-citation>
     <mixed-citation xml:lang="en">Gkouveris I., Hadaya D., Soundia A., Bezouglaia O., Chau Y., Dry S.M. et al. Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ). Bone. 2019;123:234-245. https://doi.org/10.1016/j.bone.2019.03.031</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Hong B.Y., Sobue T., Choquette L., Dupuy A.K., Thompson A., Burleson J.A. et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7(1):66. https://doi.org/10.1186/s40168-019-0679-5</mixed-citation>
     <mixed-citation xml:lang="en">Hong B.Y., Sobue T., Choquette L., Dupuy A.K., Thompson A., Burleson J.A. et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7(1):66. https://doi.org/10.1186/s40168-019-0679-5</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Zadik Y. Clarithromycin as the empiric antibiotic therapy for medication-related osteonecrosis of the jaw in multiple myeloma patients. Oral oncology. 2018;84:104-105. https://doi.org/10.1016/j.oraloncology.2018.07.016</mixed-citation>
     <mixed-citation xml:lang="en">Zadik Y. Clarithromycin as the empiric antibiotic therapy for medication-related osteonecrosis of the jaw in multiple myeloma patients. Oral oncology. 2018;84:104-105. https://doi.org/10.1016/j.oraloncology.2018.07.016</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Багрова С.Г., Копп М.В., Кутукова С.И., Манзюк Л.В., Семиглазова Т.Ю. Использование остеомодифицирующих агентов (ОМА) для профилактики и лечения патологии костной ткани при злокачественных новообразованиях. Malignant tumours. 2020;10(3s2-2):35-44. [Bagrova S.G., Kopp M.V., Kutukova S.I., Manzyuk L.V., Semiglazova T.Yu. The use of osteomodifying agents (OMA) for the prevention and treatment of bone tissue pathology in malignant neoplasms. Malignant tumours. 2020;10(3s2-2):35-44. (In Russ.)]. https://doi.org/10.18027/2224-5057-2020-10-3s2-38</mixed-citation>
     <mixed-citation xml:lang="en">Bagrova S.G., Kopp M.V., Kutukova S.I., Manzyuk L.V., Semiglazova T.Yu. Ispol'zovanie osteomodificiruyuschih agentov (OMA) dlya profilaktiki i lecheniya patologii kostnoy tkani pri zlokachestvennyh novoobrazovaniyah. Malignant tumours. 2020;10(3s2-2):35-44. [Bagrova S.G., Kopp M.V., Kutukova S.I., Manzyuk L.V., Semiglazova T.Yu. The use of osteomodifying agents (OMA) for the prevention and treatment of bone tissue pathology in malignant neoplasms. Malignant tumours. 2020;10(3s2-2):35-44. (In Russ.)]. https://doi.org/10.18027/2224-5057-2020-10-3s2-38</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Виноградова Н.Г., Харитонова М.П., Львов К.В., авторы; Муниципальное автономное учреждение «Центральная городская клиническая больница № 23», патентообладатель. Способ лечения медикаментозно ассоциированного остеонекроза челюсти. Российская Федерация патент RU 2745476. Опубл. 25.03.2021. [Vinogradova N.G., Kharitonova M.P., Lvov K.V., inventors; Municipal Autonomous Institution &quot;Central City Clinical Hospital No. 23&quot;, assignee. Method for the treatment of drug-associated osteonecrosis of the jaw. Russian Federation patent RU 2745476. Published: 25.03.2021. (In Russ.)]. https://elibrary.ru/item.asp?id=45807537</mixed-citation>
     <mixed-citation xml:lang="en">Vinogradova N.G., Haritonova M.P., L'vov K.V., avtory; Municipal'noe avtonomnoe uchrezhdenie «Central'naya gorodskaya klinicheskaya bol'nica № 23», patentoobladatel'. Sposob lecheniya medikamentozno associirovannogo osteonekroza chelyusti. Rossiyskaya Federaciya patent RU 2745476. Opubl. 25.03.2021. [Vinogradova N.G., Kharitonova M.P., Lvov K.V., inventors; Municipal Autonomous Institution &quot;Central City Clinical Hospital No. 23&quot;, assignee. Method for the treatment of drug-associated osteonecrosis of the jaw. Russian Federation patent RU 2745476. Published: 25.03.2021. (In Russ.)]. https://elibrary.ru/item.asp?id=45807537</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Виноградова Н.Г., Харитонова М.П., Львов К.В. Применение диодного лазера при лечении медикаментозноассоциированного остеонекроза челюсти (клинический случай). Проблемы стоматологии. 2021;17(3):64-68. [Vinogradova N.G., Kharitonova M.P., L'vov K.V. The use of a diode laser in the treatment of drug-associated osteonecrosis of the jaw (clinical case). Actual problems in dentistry. 2021;17(3):64-68. (In Russ.)]. https://doi.org/10.18481/2077-7566-21-17-3-64-68</mixed-citation>
     <mixed-citation xml:lang="en">Vinogradova N.G., Haritonova M.P., L'vov K.V. Primenenie diodnogo lazera pri lechenii medikamentoznoassociirovannogo osteonekroza chelyusti (klinicheskiy sluchay). Problemy stomatologii. 2021;17(3):64-68. [Vinogradova N.G., Kharitonova M.P., L'vov K.V. The use of a diode laser in the treatment of drug-associated osteonecrosis of the jaw (clinical case). Actual problems in dentistry. 2021;17(3):64-68. (In Russ.)]. https://doi.org/10.18481/2077-7566-21-17-3-64-68</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ахмадеева Л.Р., Терегулова Д.Р. Тревожные и депрессивные состояния и их связь с болевым синдромом у пациентов, находящихся на стационарном лечении. Проблемы женского здоровья. 2012;7(2):23–28. [Akhmadeeva L.R., Teregulova D.R. Anxious and depressive states and their relation to the pain syndrome in hospitalized patients. Problemy ženskogo zdorovʹâ. 2012;7(2):23–28. (In Russ.)]. https://www.elibrary.ru/item.asp?id=17879063</mixed-citation>
     <mixed-citation xml:lang="en">Ahmadeeva L.R., Teregulova D.R. Trevozhnye i depressivnye sostoyaniya i ih svyaz' s bolevym sindromom u pacientov, nahodyaschihsya na stacionarnom lechenii. Problemy zhenskogo zdorov'ya. 2012;7(2):23–28. [Akhmadeeva L.R., Teregulova D.R. Anxious and depressive states and their relation to the pain syndrome in hospitalized patients. Problemy ženskogo zdorovʹâ. 2012;7(2):23–28. (In Russ.)]. https://www.elibrary.ru/item.asp?id=17879063</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Волков Е.А., Янушевич О.О., ред. Терапевтическая стоматология. В 3 ч. Ч. 1, Болезни зубов. Москва: ГЭОТАР-Медиа; 2012. 167 с. [Volkov E.A., Yanushevich O.O., eds. Therapeutic dentistry. In 3 pt. Pt 1, Diseases of the teeth. Moscow: GEOTAR-Media; 2012. 167 p. (In Russ.)].</mixed-citation>
     <mixed-citation xml:lang="en">Volkov E.A., Yanushevich O.O., red. Terapevticheskaya stomatologiya. V 3 ch. Ch. 1, Bolezni zubov. Moskva: GEOTAR-Media; 2012. 167 s. [Volkov E.A., Yanushevich O.O., eds. Therapeutic dentistry. In 3 pt. Pt 1, Diseases of the teeth. Moscow: GEOTAR-Media; 2012. 167 p. (In Russ.)].</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Янушевич О.О., Дмитриева Л.А., ред. Пародонтология. Национальное руководство. 2-е изд., перераб. и доп. Москва: ГОЭТАР-Медиа; 2018. 751 с. (Национальные руководства). [Yanushevich O. O., Dmitrieva L. A., eds. Periodontology. National guidelines. 2nd ed., revised and enlarged. Moscow: GOETAR-Media; 2018. 751 p. (National guidelines). (In Russ.)].</mixed-citation>
     <mixed-citation xml:lang="en">Yanushevich O.O., Dmitrieva L.A., red. Parodontologiya. Nacional'noe rukovodstvo. 2-e izd., pererab. i dop. Moskva: GOETAR-Media; 2018. 751 s. (Nacional'nye rukovodstva). [Yanushevich O. O., Dmitrieva L. A., eds. Periodontology. National guidelines. 2nd ed., revised and enlarged. Moscow: GOETAR-Media; 2018. 751 p. (National guidelines). (In Russ.)].</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Виноградова Н.Г., Харитонова М.П., Львов К.В. Анализ показателей качества жизни у пациентов с диагнозом бисфосфонатный остеонекроз. Уральский медицинский журнал. 2019;(7):90-94. [Vinogradova N.G., Kharitonov M.P., Lvov K.V. Analysis of quality of life indicators in patients diagnosed with bisphosphonate osteonecrosis. Ural Medical Journal. 2019;(7):90-94. (In Russ.)]. https://www.elibrary.ru/item.asp?id=38936710</mixed-citation>
     <mixed-citation xml:lang="en">Vinogradova N.G., Haritonova M.P., L'vov K.V. Analiz pokazateley kachestva zhizni u pacientov s diagnozom bisfosfonatnyy osteonekroz. Ural'skiy medicinskiy zhurnal. 2019;(7):90-94. [Vinogradova N.G., Kharitonov M.P., Lvov K.V. Analysis of quality of life indicators in patients diagnosed with bisphosphonate osteonecrosis. Ural Medical Journal. 2019;(7):90-94. (In Russ.)]. https://www.elibrary.ru/item.asp?id=38936710</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
